In addition, in a colitis-induced colorectal cancer model, complement activation promotes CRC tumorigenesis via activating intestinal IL-1β/IL-17A axis yet in an uncertain mouse genetic background 24. The gene discussed is IL17A; the disease is colorectal carcinoma.